HK1210805A1 - Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes - Google Patents

Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes

Info

Publication number
HK1210805A1
HK1210805A1 HK15111425.5A HK15111425A HK1210805A1 HK 1210805 A1 HK1210805 A1 HK 1210805A1 HK 15111425 A HK15111425 A HK 15111425A HK 1210805 A1 HK1210805 A1 HK 1210805A1
Authority
HK
Hong Kong
Prior art keywords
degrading enzymes
oxalate degrading
isolation
purification
spray
Prior art date
Application number
HK15111425.5A
Other languages
English (en)
Chinese (zh)
Inventor
哈密特‧司杜
李青山
阿隆‧布萊克‧科里
卡爾-古斯塔夫‧格蘭德
Original Assignee
Oxthera Intellectual Property Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP09164430.2A external-priority patent/EP2270138B1/en
Priority claimed from US12/497,275 external-priority patent/US8431122B2/en
Application filed by Oxthera Intellectual Property Ab filed Critical Oxthera Intellectual Property Ab
Publication of HK1210805A1 publication Critical patent/HK1210805A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/13—Transferases (2.) transferring sulfur containing groups (2.8)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK15111425.5A 2009-07-02 2015-11-19 Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes HK1210805A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09164430.2A EP2270138B1 (en) 2009-07-02 2009-07-02 Purification and isolation of recombinant oxalate degrading enzymes
US12/497,275 US8431122B2 (en) 2009-07-02 2009-07-02 Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes
CN201080029636.9A CN102597225B (zh) 2009-07-02 2010-07-01 重组草酸盐降解酶的纯化和分离以及含有草酸盐降解酶的喷雾干燥粒子

Publications (1)

Publication Number Publication Date
HK1210805A1 true HK1210805A1 (en) 2016-05-06

Family

ID=43028177

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15111425.5A HK1210805A1 (en) 2009-07-02 2015-11-19 Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes

Country Status (16)

Country Link
US (1) US20120189604A1 (da)
EP (1) EP2449098B1 (da)
JP (2) JP2012531186A (da)
CN (2) CN102597225B (da)
BR (1) BRPI1013956B8 (da)
CA (2) CA3012811A1 (da)
DK (1) DK2449098T3 (da)
ES (1) ES2617917T3 (da)
HK (1) HK1210805A1 (da)
HU (1) HUE030905T2 (da)
IL (1) IL216873A (da)
IN (1) IN2012DN00592A (da)
LT (1) LT2449098T (da)
PL (1) PL2449098T3 (da)
PT (1) PT2449098T (da)
WO (1) WO2011000523A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8431122B2 (en) 2009-07-02 2013-04-30 Oxthera Intellectual Property Ab Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes
US9714456B2 (en) * 2013-01-18 2017-07-25 Allena Pharmaceuticals, Inc. Crystallized oxalate decarboxylase and methods of use
CN103540569A (zh) * 2013-06-05 2014-01-29 黄虹寓 结石酶及其制备方法
DK3003358T3 (da) * 2013-06-07 2021-06-21 Allena Pharmaceuticals Inc Sammensætninger og anordninger til dialyse
CN107254453B (zh) * 2014-12-22 2019-10-25 武汉康复得生物科技股份有限公司 一种在生理pH条件下有活力的草酸氧化酶及其应用
CN116124853B (zh) * 2022-11-07 2024-01-16 东北农业大学 一种检测草酸的电化学生物传感器、制备方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8486389B2 (en) * 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
US6929940B1 (en) * 2002-08-20 2005-08-16 University Of Florida Research Foundation, Inc. Polynucleotides encoding oxalate decarboxylase from Aspergillus niger and methods of use
WO2004018634A2 (en) * 2002-08-20 2004-03-04 University Of Florida Polynucleotide encoding oxalate decarboxylase from aspergillus niger and methods of use
PL1962873T3 (pl) * 2005-12-14 2014-03-31 Oxthera Intellectual Property Ab Kompozycje farmaceutyczne zawierające bakterie zmniejszające ilość szczawianu
JP5558002B2 (ja) * 2005-12-16 2014-07-23 オクセラ インコーポレイテッド シュウ酸塩低減化のための組成物および方法
CN103272225B (zh) * 2006-08-02 2018-05-22 味之素阿尔西亚有限公司 结晶化的草酸脱羧酶和使用方法

Also Published As

Publication number Publication date
PL2449098T3 (pl) 2017-06-30
EP2449098B1 (en) 2016-12-07
JP2012531186A (ja) 2012-12-10
CN102597225A (zh) 2012-07-18
IN2012DN00592A (da) 2015-06-12
JP2016121138A (ja) 2016-07-07
US20120189604A1 (en) 2012-07-26
IL216873A (en) 2017-07-31
CN102597225B (zh) 2015-04-29
BRPI1013956B1 (pt) 2021-04-06
WO2011000523A1 (en) 2011-01-06
BRPI1013956B8 (pt) 2021-05-25
CA2767039A1 (en) 2011-01-06
JP6220845B2 (ja) 2017-10-25
CA3012811A1 (en) 2011-01-06
BRPI1013956A2 (pt) 2019-04-09
ES2617917T3 (es) 2017-06-20
CN104805067A (zh) 2015-07-29
PT2449098T (pt) 2017-03-10
IL216873A0 (en) 2012-02-29
HUE030905T2 (en) 2017-06-28
DK2449098T3 (da) 2017-03-06
EP2449098A1 (en) 2012-05-09
CA2767039C (en) 2018-09-04
LT2449098T (lt) 2017-05-25

Similar Documents

Publication Publication Date Title
HK1210805A1 (en) Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes
IL213072A0 (en) Microorganism comprising particles and uses of same
EP2442829A4 (en) Structured viral peptide compositions and methods of use
ZA201300377B (en) Combinations of rhamnolipids and enzymes for improved cleaning
ZA201107439B (en) Manufactured of high active detergent particles
IL215325A (en) Chunks of proteasome inhibitors that have been lyophilized
GB201122097D0 (en) Recombinant bacterium and methods of antgen and nucleic acid delivery
PL2408794T3 (pl) Izolacja i oczyszczanie składników serwatki
EP2504298A4 (en) PREPARATION AND PURIFICATION OF IODIXANOL
PL2391382T3 (pl) Preparat farmaceutyczny zawierający lipazę pochodzenia bakteryjnego
EP2491004A4 (en) MACROCYCLIC INHIBITORS OF SERINE PROTEASE CYMS
EP2519537A4 (en) CLEANING PROTEINS
HUS1800037I1 (hu) Eljárás rekombináns lizoszomális alfa-mannozidáz elõállítására és tisztítására
EP2433964A4 (en) PEPTIDE INDUCING SPECIFIC IMMUNE RESPONSE AGAINST XAGE-1B AND USE THEREOF
SG10201501980SA (en) Homogeneous suspension of immunopotentiating compounds and uses thereof
EP2427446A4 (en) INHIBITORS OF SIALIDASE OR SIALIDASE-SAME ENZYMES
GB0908949D0 (en) Novel polypeptides having endolysin activity and uses thereof
EP2588838A4 (en) IMMOBILIZED BUFFER PARTICLES AND USES THEREOF
TWM372051U (en) Improved structure of media play and inquiry switcher
EP2473169A4 (en) PROCESS FOR THE ISOLATION AND PURIFICATION OF ENFUMAFUNGIN
HU1000211D0 (en) Preparation of alkali silicate and lead from glass wastes
LT3281636T (lt) Rekombinantinės lizosominės alfa-manozidazės gamybos ir gryninimo būdas
EP2460814A4 (en) PEPTIDE COMPOUND AND USE THEREOF
GB0901178D0 (en) Proximity of particles
TWM372764U (en) Improved structure of ceramic sharpener